Effects of Commonly Used Medications on Mood and Choice
NCT03652740 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2026-02-02
Summary
This non-treatment study will examine how commonly used prescription or over-the-counter medications may influence mood and medication preference.
Conditions
- Healthy
Interventions
- DRUG
-
Methylphenidate
Methylphenidate hydrochloride is administered orally at 10, 20, and 40 milligeam doses.
- DRUG
-
Nicotine
Nicotine is administered orally via capsule at 1, 2, 3 and 4 milligram doses.
- DRUG
-
Capsules will contain a commonly prescribed or over-the-counter medication, or placebo. A placebo is an inactive substance that looks like the study drug, but contains no active drug.
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH - lead OTHER
Principal Investigators
-
Dustin C Lee, Ph.D. · Johns Hopkins University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-02
- Primary Completion
- 2024-02-01
- Completion
- 2024-02-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Studying the Role of Brain Molecules for Decision Making
NCT04384562 ·Status: COMPLETED ·Phase: NA
-
Effects of Drugs on Responses to Brain and Emotional Processes
NCT04053036 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Behavior Brain Responses
NCT03964350 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and Reward
NCT00600145 ·Status: WITHDRAWN ·Phase: NA
-
Role of Instructions in Nitrous Oxide Effects and Choice - 10
NCT00000258 ·Status: COMPLETED ·Phase: NA
-
Effect of Stimulant Drugs on Social Perception
NCT03790618 ·Status: COMPLETED ·Phase: PHASE1
-
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
NCT04178993 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Effects on Interpersonal Interaction
NCT05123716 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Persisting Effects of Psilocybin
NCT02971605 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Antidepressant Response of DMT Masked With Propofol
NCT06927076 ·Status: RECRUITING ·Phase: NA
-
MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
NCT05709353 ·Status: RECRUITING ·Phase: PHASE2
-
Neurochemical Modulation Cognitive Performance and Subjective Wellbeing In Healthy Controls
NCT02051153 ·Status: COMPLETED ·Phase: NA
-
Marijuana Drug Discrimination and Self-Administration
NCT00943930 ·Status: COMPLETED
-
Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans
NCT06081179 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes
NCT07214155 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
The Effect of D-cycloserine on Emotional Processing
NCT03961464 ·Status: COMPLETED ·Phase: NA
-
Influence of Medication on Functional Connectivity
NCT03612713 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Human Psychopharmacology of Salvinorin A
NCT00996411 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacological Cognitive Enhancement
NCT01684306 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Investigation of Psychedelic Effects in Psychoactive Substances
NCT06772753 ·Status: RECRUITING ·Phase: PHASE1
-
Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants
NCT05324982 ·Status: RECRUITING ·Phase: PHASE1
-
Acquisition of Responses to a Methamphetamine-associated Cue in Healthy Humans
NCT02323048 ·Status: COMPLETED ·Phase: NA
-
The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity
NCT00205946 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Dimethyltryptamine in Healthy Subjects
NCT04353024 ·Status: COMPLETED ·Phase: PHASE1
-
Back to Basics - Effects, Narratives and Routes of Administration of Open-label Placebo
NCT02578420 ·Status: COMPLETED ·Phase: NA